Evaluation of the BART test (a modification of the whole-blood activated recalcification time test) as a means of monitoring heparin therapy.
D001778:Blood Coagulation Disorders / Q000517:prevention & control; D001780:Blood Coagulation Tests; D004342:Drug Hypersensitivity; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008722:Methods; D008991:Monitoring, Physiologic; D013917:Thrombin; D013925:Thromboplastin; D013997:Time Factors
D006493:Heparin; D013925:Thromboplastin; D013917:Thrombin